The GMP Insider
von Tushar Arora
Contamination Control Strategy (CCS) Under EU GMP Annex 1
Über diesen Podcast
GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance.
Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance. Each episode explores topics like audits, CAPA, data integrity, quality systems, validation, and global regulatory expectations — all with a focus on protecting patients and building strong quality cultures.
Whether you work in Quality Assurance, Quality Control, Manufacturing, or Regulatory Affairs, GMP Insider helps you stay compliant, confident, and ahead in an ever-evolving pharmaceutical industry.
New episodes deliver:• GMP best practices• Audit readiness strategies• Real compliance case studies• Industry trends and updates• Expert tips from quality professionals
From batch to patient — quality is everything.
Folgen
Die neuesten 20 von 78 Folgen
- Contamination Control Strategy (CCS) Under EU GMP Annex 1 · 15 Min. · Folge 2Most contamination control strategies fail on page one — not because anything in them is wrong, but because everything in them is copied from somewhere else. Marcus and Priya…
- Deviation Investigation & Root Cause Analysis: 5 Whys Done Right · 15 Min. · Folge 7Most deviation investigations fail not because teams pick the wrong tool, but because they stop asking why the moment the answer becomes uncomfortable — usually at "human error"…
- How to Respond to an FDA 483 (and Warning Letter) in 15 Working Days · 15 Min.The inspection is over — and the second half of it has just started. Your written response to a Form FDA 483 is due within 15 working days, and FDA weighs it before deciding…
- FDA Inspection Readiness 2026: The New Cross-System Inspection Model · 15 Min.FDA doesn't inspect your quality systems in silos anymore. The new inspection model is hypothesis-driven: the investigator pulls one thread — a complaint, a repeat deviation —…
- Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained · 14 Min.Nearly nine out of ten human-drug warning letters include at least one inadequate CAPA response. Your corrective action plan is the single most rejected document in FDA…
- Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained · 14 Min.Nearly nine out of ten human-drug warning letters include at least one inadequate CAPA response. Your corrective action plan is the single most rejected document in FDA…
- OOS Investigation Explained: Phase 1 vs Phase 2 (21 CFR 211.192) · 15 Min.An out-of-specification result lands on your desk — and one wrong decision in the next hour can manufacture the evidence for your own warning letter. Marcus and Priya break down…
- ALCOA+ Explained: The 9 Data Integrity Principles FDA Actually Cites · 15 Min.When an FDA investigator stops trusting your data, the inspection is over — because if the records can't be trusted, nothing built on them can be. Marcus and Priya break down all…
- Top 10 FDA 483 Observations in 2026 (and How to Avoid Each One) · 13 Min.Every year, FDA investigators write thousands of 483 observations — and almost every one was avoidable. Marcus and Priya count down the ten most-cited observations in drug…
- Quality Debt: The Hidden Liability Inside Pharmaceutical Quality Systems · 7 Min.Every shortcut, deferred CAPA, and "we'll fix it later" is a loan — and quality debt charges interest. Repeat deviations, findings, and warning letters are just the payments…
- The Hidden Cost of Poor Quality: The Business Impact Beyond Recalls · 16 Min.Recalls make the headlines. But the real cost of poor quality never makes the press release — it hides in rework, investigations, remediation, and the launches that never…
- Why CAPA Doesn't Fix Culture: Symptoms vs Systems · 11 Min.Your CAPA system can be perfect on paper and still change nothing — because CAPAs fix symptoms, and culture is the system underneath.• Why brilliant CAPAs die in broken cultures•…
- Compliance vs Effectiveness: Is Your Quality System Healthy? · 11 Min.Compliant doesn't mean effective. Effective doesn't mean sustainable. Most quality systems are only one of the three — and leadership can't tell which.• The three lenses every…
- When a Green Dashboard Lies: Signals Your Metrics Miss · 8 Min.Every metric green, every trend flat — and the system is rotting underneath. Dashboards don't lie on purpose. They lie by design.• Why green metrics create dangerous comfort• The…
- When Quality Has to Say NO: Tough QA Decisions in Pharma · 20 Min.Saying no in QA is easy on paper and brutal in practice. This episode is about the decision nobody wants to make — and why making it is the job.• Why "no" is a quality decision…
- AI Governance in Pharma: Ethics by Design for Quality Leaders · 45 Min.AI governance in the pharmaceutical industry cannot begin after deployment. By that point, critical decisions about data, accountability, human oversight, transparency, risk, and…
- Big Pharma vs Small Pharma: Where Quality Culture Thrives · 18 Min.What is it really like to work in Quality Assurance at a large pharmaceutical company compared with a smaller organization? The answer goes far beyond company size. In this…
- The Human Side of Pharma Quality: Quality Is Love in Action · 19 Min.What if the deepest meaning of Pharmaceutical Quality isn't compliance? What if it's caring? Every SOP written, every deviation investigated, every batch reviewed, and every…
- QA Leadership: Making Difficult Quality Decisions with Confidence · 18 Min.Some of the hardest decisions in Pharmaceutical Quality are not difficult because the answer is unclear. They're difficult because the right answer isn't necessarily the popular…
- The Most Dangerous Day in Quality: When Questions Stop · 18 Min.The most dangerous day in Pharmaceutical Quality isn't necessarily the day an inspector arrives. It may be the day people stop asking questions. A Quality System can appear…








